کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1393911 1501109 2016 19 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
ترجمه فارسی عنوان
نقش اساسی گلیکوزین سیتستاز کیناز 3: یک هدف درمانی برای بیماری آلزایمر
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آلی
چکیده انگلیسی


• GSK-3 has an evident role in the formation of both senile plaques and neurofibrillary tangles, the two main hallmarks of AD.
• ATP competitive inhibitors lack the efficient selectivity which are of main concern of development.
• GSK-3 inhibitors have been found to increase adult hippocampal neurogenesis.
• Majority of the reported GSK-3 inhibitors lie in the clinical trial phases.

Neurodegenerative diseases are among the most challenging diseases with poorly known mechanism of cause and paucity of complete cure. Out of all the neurodegenerative diseases, Alzheimer's disease is the most devastating and loosening of thinking and judging ability disease that occurs in the old age people. Many hypotheses came forth in order to explain its causes. In this review, we have enlightened Glycogen Synthase Kinase-3 which has been considered as a concrete cause for Alzheimer's disease. Plaques and Tangles (abnormal structures) are the basic suspects in damaging and killing of nerve cells wherein Glycogen Synthase Kinase-3 has a key role in the formation of these fatal accumulations. Various Glycogen Synthase Kinase-3 inhibitors have been reported to reduce the amount of amyloid-beta as well as the tau hyperphosphorylation in both neuronal and nonneuronal cells. Additionally, Glycogen Synthase Kinase-3 inhibitors have been reported to enhance the adult hippocampal neurogenesis in vivo as well as in vitro. Keeping the chemotype of the reported Glycogen Synthase Kinase-3 inhibitors in consideration, they may be grouped into natural inhibitors, inorganic metal ions, organo-synthetic, and peptide like inhibitors. On the basis of their mode of binding to the constituent enzyme, they may also be grouped as ATP, nonATP, and allosteric binding sites competitive inhibitors. ATP competitive inhibitors were known earlier inhibitors but they lack efficient selectivity. This led to find the new ways for the enzyme inhibition.

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Medicinal Chemistry - Volume 107, 1 January 2016, Pages 63–81
نویسندگان
, , ,